Part D Open Enrollment and GLP 1 Injections The 2 400 Cap Explained

For many Medicare beneficiaries, the annual Part D Open Enrollment period is the main opportunity to review drug coverage and make changes for the coming year. It is also a critical window for anyone using GLP-1 injections, because these medications can be expensive and coverage rules vary widely by plan. Understanding how enrollment, formularies, and out-of-pocket limits interact can help you avoid surprises at the pharmacy counter.

Medicare Part D Open Enrollment Basics

Medicare Part D Open Enrollment generally runs from October 15 to December 7 each year. During this time, people with Medicare can join a Part D plan, switch plans, or drop coverage. Changes made during enrollment usually take effect on January 1. It is important to review your plan’s Annual Notice of Change, which explains updates to premiums, deductibles, covered drugs, and pharmacy networks. Even if you are satisfied with your current plan, checking the details can reveal whether your GLP-1 injection will remain covered on the same terms.

GLP-1 Coverage and Prescription Insurance

GLP-1 injections such as semaglutide and tirzepatide are covered differently depending on the diagnosis and the plan. Part D plans typically cover GLP-1 medications approved for diabetes, but coverage for obesity alone is often excluded unless the drug has an additional approved indication, such as reducing cardiovascular risk. Some Medicare Advantage plans may offer extra coverage, but rules vary. Your prescription insurance may require prior authorization, step therapy, or quantity limits. Checking the plan’s formulary before enrollment helps confirm whether your specific injection and dose are included.

The $2,400 Cap Explained

The $2,400 cap is sometimes mentioned in Medicare drug coverage discussions, but it is not the standard Part D out-of-pocket threshold for every year. The official annual out-of-pocket cap was $2,000 in 2025 and is $2,100 in 2026. A $2,400 figure may appear in older estimates, specific plan materials, or proposals that did not become the final rule. What matters is your plan year and your plan’s benefit design. Once you reach the annual cap, you generally pay $0 for covered Part D drugs for the rest of the year, but only if the drugs are on formulary and meet plan rules.

Formulary, Pharmacy, and Prior Authorization

A formulary is the list of prescription drugs a plan covers. It can place GLP-1 injections on different tiers, which affects copays and deductible requirements. Prior authorization means the plan must approve the medication before it is covered. Some plans also require step therapy, where you try a preferred drug first. Using an in-network pharmacy is important because out-of-network pharmacies may not be covered or may charge more. Mail-order pharmacy services can sometimes provide a 90-day supply, but confirm that your injection dose and refill schedule are supported.

Copay, Deductible, and Savings Options

Your copay is the fixed amount you pay for a covered prescription, while the deductible is what you pay before some coverage begins. Part D plans set their own tiers, so a GLP-1 injection might have a $0 copay, a $35 copay, or a percentage coinsurance. Manufacturer savings programs, pharmacy discount cards, and state pharmaceutical assistance programs may help, but they cannot always be combined with Medicare. If you have limited income, Extra Help or a Medicare Savings Program may reduce premiums and cost sharing. Always ask the plan and pharmacy for a written estimate.

Telehealth, Obesity, Medication Dose, and Refill

Telehealth has become a common way to manage obesity and diabetes care, especially for medication adjustments and refill approvals. A telehealth visit can help your clinician document the diagnosis and submit prior authorization paperwork. However, Medicare Part D does not cover weight loss drugs solely for obesity, so the prescription must meet coverage criteria. Your medication dose may change over time, and each dose strength can have a different coverage status. Refill rules, vacation overrides, and quantity limits can also affect whether you can fill your injection on time.

Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.

The table above shows list prices, not what you will necessarily pay. With Part D coverage, your cost depends on the plan’s tier, deductible, copay, and whether you qualify for Extra Help. A $2,400 cap may apply in some plan materials or older estimates, but the standard Part D cap for covered drugs is $2,000 in 2025 and $2,100 in 2026. Always verify current figures with Medicare or your plan.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

The key takeaway is that Part D Open Enrollment is the time to compare plans, check formulary coverage for GLP-1 injections, and understand your true out-of-pocket costs. The $2,400 cap figure should be checked against the official Part D threshold for your plan year. By reviewing enrollment materials, pharmacy networks, and prior authorization rules, you can make a more informed decision about your prescription insurance and medication refills.